Phenotypical characteristics of the immune cells in allergic contact dermatitis, atopic dermatitis and pityriasis rosea.
Allergic contact dermatitis (ACD) is a cell-mediated, delayed type IV immunologic reaction. Atopic dermatitis (AD) is a chronic inflammatory skin disease that results from a complex interaction between immunologic, genetic, and environmental factors. Pityriasis rosea (PR) is a self-limited eruption of unknown etiology. Immune cell infiltrate is a constant feature in the inflammatory skin diseases. Here, we performed phenotypical characterization of the immune cells in ACD, AD and PR (ten cases each). We performed immunohistochemical stains for B cells (CD20), T cells (CD3), histiocytes (CD68) and T cells with cytotoxic activity (granzyme-B). The data were compared with findings in 20 specimens of normal skin. The results were scored as mean values of positively stained immune cells. Immunohistochemistry showed significantly high counts of immune cells in lesional skin (ACD, AD and PR) compared to the normal one (p < 0.05). In the lesional skin, the immune cells were composed predominantly of CD3(+) T lymphocytes and CD68(+) cells (histiocytes). Some of the CD3(+) cells were granzyme B(+). The counts of some immune cells (CD3(+) and CD68(+)) were high in ACD compared to AD and PR. The counts of CD20(+) and granzyme B(+) cells were high in PR compared to ACD and AD. However, these differences did not reach the level of statistical significance. The present data describe the profile of the immune cell infiltrate in AD, ACD and PR. The cell-mediated immunity seems to have critical role in the development of these lesions.
Hussein
Mahmoud Rezk A
MR
Department of Pathology, Assuit University Hospitals, Assuit University, Assuit, Egypt. mrcpath17@gmail.com
Abdel-Magid
Wafaa M
WM
Saleh
Ramadan
R
Nada
Essam
E
D016022:Case-Control Studies; D017449:Dermatitis, Allergic Contact / Q000276:immunology* / Q000473:pathology; D003876:Dermatitis, Atopic / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007111:Immunity, Cellular / Q000502:physiology*; D007124:Immunoenzyme Techniques; D016130:Immunophenotyping; D017515:Pityriasis Rosea / Q000276:immunology* / Q000473:pathology; D012867:Skin / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology
Int J Dermatol. 2001 Aug;40(8):489-94
11703518
J Invest Dermatol. 1992 Feb;98(2):166-70
1370676
Br J Dermatol. 2005 Jul;153(1):18-21
16029321
Ann Acad Med Singap. 2000 Jul;29(4):548
11056789
Int J Dermatol. 2004 Dec;43(12):870-5
15569005
Am J Pathol. 2001 Mar;158(3):803-8
11238028
Cancer Biol Ther. 2005 Oct;4(10):1075-8
16123584
Clin Exp Immunol. 1991 Dec;86(3):444-8
1721013
Br J Dermatol. 2001 Jun;144(6):1133-9
11422032
Clin Exp Allergy. 2001 Nov;31(11):1724-31
11696048
Curr Drug Targets Inflamm Allergy. 2003 Mar;2(1):81-94
14561178
Br J Dermatol. 2007 Feb;156(2):312-9
17223872
J Clin Pathol. 2006 Mar;59(3):316-24
16505286
Cancer Biol Ther. 2005 Aug;4(8):819-21
16210913
Br J Dermatol. 2001 Dec;145(6):957-65
11899150
J Cutan Pathol. 1996 Jun;23(3):270-4
8793664
Tidsskr Nor Laegeforen. 2002 Mar 20;122(8):793-6
12092071
Arch Dermatol Res. 2001 Aug;293(8):420-6
11686518
Arch Dermatol Res. 1995;287(2):137-41
7763084
Clin Pediatr (Phila). 1983 Mar;22(3):200-3
6825364
Eur Rev Med Pharmacol Sci. 2001 May-Jun;5(3):95-117
12004919
J Invest Dermatol. 1991 Mar;96(3):370-5
2002256
Contact Dermatitis. 2002 Nov;47(5):257-66
12534529
Immunology. 1998 Feb;93(2):281-8
9616380
Curr Biol. 1997 Nov 1;7(11):836-43
9480044
Contact Dermatitis. 1997 Oct;37(4):163-72
9385511
Cutis. 2001 Dec;68(6):387-96
11775771
Arch Dermatol Res. 1989;281(1):24-30
2525009
Arch Dermatol Res. 2002 Oct;294(7):297-302
12373334
Fertil Steril. 2005 May;83(5):1447-53
15866583
Acta Derm Venereol. 1988;68(3):209-17
2455413